Which men with non-malignant pathology at magnetic resonance imaging-targeted prostate biopsy and persistent PI-RADS 3-5 lesions should repeat biopsy?

Daniele Castellani, Tiziana Pierangeli, S Cecchini et al.|Urologic Oncology Seminars and Original Investigations|2022

Cited by 3